Куркума при болях в суставах: что на самом деле показывают последние исследования

Более 53 миллионов взрослых жителей США страдают от диагностированного артрита, и в последние годы доля тех, кто жалуется на сильные боли в суставах, несколько возросла. Исследователи продолжают изучать экстракты куркумы и куркумин на предмет ...

Сообщение Planet-Today.com. Перевод заголовка и краткого описания выполнен автоматически.


More than 53 million U.S. adults live with diagnosed arthritis, and the share reporting severe joint pain has edged higher in recent years. Researchers keep testing turmeric extracts and curcumin for relief. Some trials look promising. Others do not. The gap between the headlines and the full picture is worth a closer look.

Turmeric for Joint Pain: What the Latest Trials Actually Show

Joint pain sends millions of people looking for something that eases stiffness without the stomach upset that often comes with common pain pills. Turmeric has been part of kitchen cabinets and older medical traditions for a long time. The bright yellow root contains curcuminoids, and curcumin is the one studied most often for its effects on swelling. A report published October 5, 2026, by registered dietitian Molly Knudsen reviewed the evidence and noted that concentrated extracts may help some people with osteoarthritis feel better and move more easily. MindBodyGreen

That report sits next to older reviews and a few newer trials that paint a more mixed picture. One recent combination study found no clear edge over a placebo. The difference often comes down to the exact product used, the dose, how well the body absorbs it, and how the trial was set up. Readers who want the unfiltered view have to hold both the positive signals and the limits at the same time.

How common is the problem these studies try to address?

The Centers for Disease Control and Prevention reported that 53.2 million U.S. adults (21.2 percent) had been told by a doctor they had arthritis in the 2019–2021 period. Among those with arthritis, the median percentage across states who said they had severe joint pain rose from 29.7 percent in 2015 to 32.8 percent in 2019. Southeastern states tended to show the highest rates. CDC MMWR CDC state data

Those numbers explain why interest in non-drug options stays high. Arthritis limits activity for many people and contributes to overall health costs. Standard care often starts with exercise advice, weight management when needed, and pain medicines when symptoms are strong. Some of those medicines can irritate the stomach or raise other concerns with longer use. That leaves room for researchers to test plant compounds that act on inflammation pathways.

What the larger reviews have found

A 2021 systematic review and meta-analysis looked at 16 randomized controlled trials that together included 1,810 adults with knee osteoarthritis. Turmeric extracts reduced knee pain and improved physical function more than placebo. The size of the effect was in the same range as results seen with some over-the-counter pain relievers. The same analysis found fewer adverse events than with non-steroidal anti-inflammatory drugs and rates similar to placebo. Heterogeneity was high, and body-mass index explained part of the variation—people with higher BMI saw smaller gains. No clear changes appeared in blood markers or imaging in the studies that checked those outcomes. Wang et al., Current Rheumatology Reports 2021

A separate 2021 systematic review of 10 trials of turmeric or curcumin extracts in knee osteoarthritis found that every study reported improvements in pain and function from the start of treatment. When three of those trials compared turmeric to non-steroidal anti-inflammatory drugs, the scores ended up similar. Paultre et al., BMJ Open Sport & Exercise Medicine 2021

A 2023 meta-analysis of six studies involving 539 people with rheumatoid arthritis reported that curcumin improved several measures of disease activity, including counts of tender and swollen joints, plus markers such as C-reactive protein and erythrocyte sedimentation rate. Smaller 2025 work on hand osteoarthritis (27 adults over age 50 taking 170 milligrams of curcumin daily for three months) saw gains in pain at rest, pain with activity, and hand function, though the sample was too small for firm conclusions.

A July 2025 network meta-analysis of 17 trials reached a similar overall conclusion: all turmeric preparations reduced pain and improved function in knee osteoarthritis compared with placebo. Bioavailability-enhanced forms reached a threshold that some experts consider clinically meaningful. BMC Complementary Medicine and Therapies 2025 Planet Today covered related 2025 findings earlier this year in Turmeric Curcumin Rivals Arthritis Pain Drugs.

Why absorption changes the results

Curcumin is hard for the body to absorb and leaves the system quickly. Plain turmeric powder used in cooking contains only a small percentage of curcuminoids, so the amounts that reach the blood from kitchen use are far lower than the doses tested in most trials. Many supplements therefore use special formulations or add piperine from black pepper. Studies have shown that piperine can raise curcumin’s bioavailability by roughly 2,000 percent. Other approaches include phospholipid complexes, micronized particles, or water-dispersible forms.

Most joint-pain research has used 500 to 1,000 milligrams of turmeric extract daily. There is no single agreed-upon “best” dose, and higher amounts can be hard on the liver in some people. Knudsen’s October 2026 review advised looking for products that state their curcuminoid content clearly and use a delivery system meant to improve absorption. The same point appears in earlier work: without an absorption boost, turmeric usually does not deliver the effects associated with the concentrated extracts.

A recent trial that did not separate from placebo

Not every study shows a clear benefit. A 12-week double-blind randomized trial published in 2026 (the ATLAS trial, conducted in Australia) tested a combination that included 500 milligrams of curcumin plus piperine, boswellia, pine bark extract, and methylsulfonylmethane against placebo in 84 adults with symptomatic knee osteoarthritis confirmed by X-ray. Both groups saw their pain scores drop by about 20 points on a 100-point scale. The difference between the groups was essentially zero (0.16 mm, with a confidence interval that crossed no effect). Safety looked similar. The authors concluded the combination was not superior to placebo for pain over 12 weeks and that the evidence does not support using that particular mix for symptomatic knee osteoarthritis. Osteoarthritis and Cartilage 2026, DOI 10.1016/j.joca.2026.06.008

That result does not erase the earlier positive meta-analyses. It does show that product choice, exact dose, other ingredients in the capsule, and trial design matter. Some positive trials used standardized extracts alone or with proven absorption enhancers; others tested different blends. Short trial lengths (often 8–12 weeks) and moderate risk of bias in parts of the older literature also leave room for caution. One well-known earlier trial found symptom relief without measurable change in cartilage volume or joint swelling on MRI, which means the pain benefit did not equal structural repair in that study.

What traditional use and modern data both leave open

Turmeric has a long record as both food and medicine in older systems. Modern trials have largely tested concentrated extracts rather than the amounts people add to curries. The anti-inflammatory action is linked to effects on pathways such as NF-κB and COX-2, which can lower certain cytokines and prostaglandins. Antioxidant activity is also described in laboratory work. Those mechanisms make biological sense for joint symptoms driven by inflammation. They do not automatically translate into disease-modifying effects or into the same results for every person or every product.

Alternative outlets have kept a wider list of curcumin studies in view, including work on other inflammatory conditions. Mainstream reviews tend to stress the heterogeneity, the need for larger longer trials, and the fact that supplements are not interchangeable. Both observations can be true at once. People who already take blood thinners, diabetes medicines, or certain other drugs should check with a clinician because curcumin can affect how the body processes some compounds. High doses are not risk-free for the liver. Culinary amounts are generally viewed as safe for most healthy adults.

Related coverage on this site has examined turmeric in other contexts, including a small open study on memory scores in older adults (Turmeric Memory Study: What Ten Patients and No Placebo Leave Open) and broader questions about long-term inflammation (Silent Inflammation May Reshape the Heart Years Before Pain). Those pieces underline the same pattern: signals appear in some designs and fade or stay unproven in others.

Practical points that follow from the data

If joint pain is the main concern, the strongest signals so far sit with standardized curcumin extracts formulated for better absorption, used for several weeks, in people with osteoarthritis. Effects on pain scores and function measures have been statistically significant versus placebo in pooled analyses and often similar to short-term non-steroidal anti-inflammatory drugs, with fewer stomach-related complaints in the comparisons that measured that outcome. Rheumatoid arthritis data are smaller but point in a similar direction on disease-activity scores.

Kitchen turmeric alone is unlikely to match trial doses. Adding black pepper or fat may help a little with absorption, but the research that shows clearer symptom changes used higher, standardized amounts. Results, when they appear, often take 4–12 weeks. Individual responses vary. The supplements do not replace exercise, weight management when relevant, or medical care for underlying joint disease. They are also not proven to rebuild cartilage.

Readers comparing products will notice large differences in curcuminoid percentage, added piperine or other enhancers, and price. Third-party testing for purity is one practical check because supplement quality is not uniform. Anyone considering a trial of a product should discuss it with a clinician who knows their full medication list and liver history.

The picture that sits between the extremes

The October 2026 dietitian review and the earlier meta-analyses give a reasonable basis for interest in turmeric extracts for joint symptoms. The 2026 combination trial that matched placebo shows why blanket claims are hard to defend. Traditional use supplies historical context; modern controlled trials supply the measurable pain and function scores. Neither side of the conversation is complete without the other. Formulation, dose, absorption, trial quality, and the specific joint condition all change the odds of seeing a difference.

For people already dealing with daily stiffness, the practical next step is the same one the reviewed report suggested: talk with a health-care provider about whether a well-characterized curcumin product fits alongside the rest of their care. The data support cautious optimism for symptom relief in some cases of osteoarthritis. They do not support treating turmeric as a universal fix or ignoring the studies that failed to separate from placebo.

Original source: “Research Shows This Anti-Inflammatory Supplement Can Help Ease Joint Pain,” Molly Knudsen, M.S., RDN, MindBodyGreen, October 5, 2026. Full article

Disclaimer for fact-checkers: This article draws on peer-reviewed systematic reviews, randomized trials, and CDC surveillance data. Effect sizes vary by product and study quality. Not all turmeric preparations have been shown to outperform placebo. Readers should consult primary sources and qualified clinicians before changing treatment.

Отправить комментарий

Здесь вы можете оставить свой комментарий

Новые Старые

Форма для связи